| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |